Prometheus Biosciences
RXDX
$199.92
Share price
0.00%
Change (1 day)
360.96%
Change (1 year)
Categories
Revenue for Prometheus Biosciences (RXDX)
Revenue in 2023 (TTM): $3.99 M
According to Prometheus Biosciences's latest financial reports the company's current revenue (TTM) is $3.99 M. In 2022 the company made a revenue of $6.8 M an increase over the years 2021 revenue that were of $3.12 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Prometheus Biosciences from 2020 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $3.99 M | -41.33% |
| 2022 | $6.8 M | 117.61% |
| 2021 | $3.12 M | 154.6% |
| 2020 | $1.22 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Epizyme EPZM | $53 M | 1,226.86% | 🇺🇸 USA |
 Akebia Therapeutics AKBA | $0.20 B | 4,922.45% | 🇺🇸 USA |
 Agenus
AGEN | $99.35 M | 2,387.01% | 🇺🇸 USA |